Weil et al., 2002 - Google Patents
Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction resultWeil et al., 2002
View HTML- Document ID
- 9846606242633078469
- Author
- Weil A
- Glaser C
- Amad Z
- Forghani B
- Publication year
- Publication venue
- Clinical Infectious Diseases
External Links
Snippet
Patients with Suspected Herpes Simplex Encephalitis: Rethinking an Initial Negative
Polymerase Chain Reaction Result | Clinical Infectious Diseases | Oxford Academic Skip to
Main Content Advertisement Oxford Academic Journals Books Search Menu Information …
- 208000000903 Herpes Simplex Encephalitis 0 title abstract description 26
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/324—Management of patient independent data, e.g. medical references in digital format
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Weil et al. | Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result | |
Mao et al. | Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China | |
Raschilas et al. | Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study | |
Wang et al. | Characterization of an asymptomatic cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected individuals outside of Wuhan, China | |
Walter et al. | Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients | |
Isaacson et al. | Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis | |
Glaser et al. | In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998—2000 | |
Hassanein et al. | Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy | |
Ogrinc et al. | Suspected early Lyme neuroborreliosis in patients with erythema migrans | |
Noska et al. | The role of antiviral therapy in immunocompromised patients with herpes simplex virus meningitis | |
Fernández-Sabé et al. | Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system | |
O’Halloran et al. | Pitfalls associated with the use of molecular diagnostic panels in the diagnosis of cryptococcal meningitis | |
Knight et al. | Effects of pediatric HIV infection on mental and psychomotor development | |
Lozier et al. | Prolonged detection of Zika virus nucleic acid among symptomatic pregnant women: a cohort study | |
Troy et al. | Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir | |
Tamula et al. | Cognitive decline with immunologic and virologic stability in four children with human immunodeficiency virus disease | |
Christie et al. | Diagnostic challenges of central nervous system tuberculosis | |
Leake et al. | Pediatric acute hemorrhagic leukoencephalitis: report of a surviving patient and review | |
Kobayashi et al. | Clinical characteristics of patients with coronavirus disease 2019 in Japan: a single-center case series | |
Mashi et al. | The association of health literacy with glycemic control in Saudi patients with type 2 diabetes | |
Algahtani et al. | Assessment of the burden of multiple sclerosis patients' caregivers in Saudi Arabia | |
Lucas et al. | Diagnosis of 2009 pandemic influenza A (pH1N1) and seasonal influenza using rapid influenza antigen tests, San Antonio, Texas, April–June 2009 | |
Fiorito et al. | Neonatal conjunctivitis caused by Neisseria cinerea: a case of mistaken identity | |
Duque-Silva et al. | Outcomes of pediatric central nervous system tuberculosis in California, 1993–2011 | |
Fokuoh et al. | Longitudinal analysis of apoe-ε4 genotype with the logical memory delayed recall score in Alzheimer’s disease |